Calling Them “Vanity Drugs,” Some Insurers Refuse to Cover New Anti-Obesity Drugs
August 3, 2022
In an interview with Pharmacy Times, Ron Lanton III, Esq., principal at Lanton Law, discussed why insurers are refusing to cover new, highly effective anti-obesity drugs and how some prescribers are getting around the issue. Lanton said that this is a common issue across many different disease spaces and drug types, but some policy changes may be able to help.
Read the source article at Pharmacy Times
2022-06-23 23:00:00
